Close Menu

NEW YORK – Roche announced Wednesday that its CINtec Plus Cytology test for women with the human papillomavirus infection who are at risk of cervical cancer has been approved by the US Food and Drug Administration.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.